dc.contributor.author |
Knapp, Steven |
en_US |
dc.date.accessioned |
2013-12-16T17:53:01Z |
|
dc.date.accessioned |
2019-09-08T02:36:34Z |
|
dc.date.available |
2013-12-16T17:53:01Z |
|
dc.date.available |
2019-09-08T02:36:34Z |
|
dc.date.issued |
2008 |
|
dc.identifier |
317399547 |
en_US |
dc.identifier.other |
b20437092 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/1989/10775 |
|
dc.description |
xv, 229 leaves : ill. ; 29 cm. |
en_US |
dc.description.abstract |
The following details the synthesis of a novel bis(1,2,3-triazole), which is a potential glycosyltransferase inhibitor. A glycosyltransferase is an enzyme that is involved in the synthesis of polysaccharides, for example the capsule that protects Staphylococcus aureus. Bis(1,2,3-triazoles) may mimic the UDP conjugates of aminosugars (D-ManNAcA, D-FucNAc, and L-FucNAc) found in the capsular polysaccharide of S. aureus, and may prevent the formation of the capsular polysaccharide leaving the bacteria open to attack by phagocytosis or antibiotics. Bis(1,2,3-triazole) groups will be used to replace the phosphate linkages in the UDP-parent aminosugars. Bis(1,2,3-triazoles) may mimic the diphosphate linkage in binding to a transferase due to the N-3 lone pairs on the heterocycles. |
en_US |
dc.description.statementofresponsibility |
by Steven E. Knapp. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.relation.ispartofseries |
Master's Theses no. 1131 |
en_US |
dc.subject.lcsh |
Glycosyltransferases--Inhibitors. |
en_US |
dc.subject.lcsh |
Staphylococcus aureus infections--Prevention. |
en_US |
dc.title |
Synthesis and Structural Analysis of Novel Bis(triazole) UDP Analogs as Potential Glycosyl Transferase Inhibitors |
en_US |
dc.type |
Thesis |
en_US |